Sky to broadcast sharper football matches and movies from August July 14, 2016 Broadcaster Sky is going to offer a range of channels and programmes in Ultra HD from August. The move is part of Sky’s Q Silver service, and subscribers will need a supported TV-top box and TV that allows the format to watch. The picture quality offered by Ultra HD can be up to four times that [...]
At the close: FTSE 100 gives up its gains after Bank of England puts rate rise on hold until August July 14, 2016 The Bank of England dashed market hopes of a further rate cut for at least another month today, sending the FTSE 100 off its 11-month highs. Having rallied to a peak of 6,743.42 before the Bank of England's decision, the FTSE 100 crashed to earth, closing down 0.2 per cent at 6,654.47 points. Most analysts thought the Bank would [...]
Delta Air Lines propelled by lower fuel costs as revenue bombs July 14, 2016 Delta Air Lines, the oldest airline still operating in the US, has posted results in line with expectations, with a decline in revenue being offset by the low oil price. The figures The airline reported a 4.1 per cent increase in net earnings for the second quarter, climbing to $1.5bn (£1.1bn), or $2.03 per share. Delta's revenue dropped 2.4 per [...]
Before the bell: What you need to know before the US market open July 14, 2016 The Bank of England has kept interest rates on hold, stunning the market and sending the pound sharply upwards. Here's what you need to know ahead of the US market open at 2:30pm London time. US futures are pointing higher, signalling what could be another day of broken all-time-highs for indices. The S&P is up [...]
BlackRock falls short of expectations due to low pound and wary investors July 14, 2016 The world’s largest asset manager BlackRock has missed expectations in its second quarter. Revenue is down three per cent to $2.8bn (£2bn), net income declined four per cent to $789m, while assets under management also fell four per cent on last year to $4.89 trillion. BlackRock’s adjusted earnings per share for the quarter were $4.78, falling short of an analyst consensus of $4.81. The New York [...]
Brexit brushed off by up beat UK jobs market July 14, 2016 The number of UK jobs available climbed in June, despite fears surrounding the last months vote to quit the European Union. The market shrugged off the Brexit vote adding 9,060 jobs, an increase of 18 per cent from May. However the number of jobs going is down by 30 per cent compared to June last [...]
Economists for Brexit call for the government to unilaterally dismantle all trade tariff barriers July 13, 2016 A renegade group of pro-Brexit economists have laid out their plans for how the UK should navigate the instability caused by the UK leaving the European Union. They claim UK GDP could grow by 2.3 per cent this year and 2.7 per cent in 2017 if the government follows their advice to unilaterally dismantle all [...]
At the close: FTSE 100 dips as pre-BoE jitters seize European markets July 13, 2016 The FTSE 100 has dialled back its earlier gains to skid at the close this evening. The blue-chip index finished down just a touch at 6,670.40, off by 10 points – or 0.15 per cent. It's the second flat close on the bounce for the FTSE 100 after ending yesterday's session unchanged. It had earlier in today's session climbed to 6,717.17. The [...]
Before the bell: What you need to know before the US market open July 13, 2016 US stock markets are at a record high, Opec production is at its highest level in eight years, and China's trade surplus narrowed. Here's what you need to know before the US market open at 2:30pm London time. US futures are pointing up ahead of the open, though are not looking quite as rosy as in recent sessions. The S&P [...]
Large Valeant shareholder gives up stake amid mounting losses July 13, 2016 An investor letter has revealed that one of Valeant Pharmaceuticals largest shareholders has ditched its stake in the firm over the last quarter. Mutual fund Sequoia told investors (the letter can be read here) it no longer owned any shares of Valeant, the controversial pharma firm that has grown quickly in recent years through acquisitions and drug price hikes. At [...]
